These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7014785)

  • 1. Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection.
    Bowen GS; Rayfield EJ; Monath TP; Kemp GE
    J Med Virol; 1980; 6(3):227-34. PubMed ID: 7014785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-induced pancreatic disease by Venezuelan encephalitis virus. Alterations in glucose tolerance and insulin release.
    Rayfield EJ; Gorelkin L; Curnow RT; Jahrling PB
    Diabetes; 1976 Jul; 25(7):623-31. PubMed ID: 776726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Venezuelan equine encephalitis virus infection and diabetes in Zulia State, Venezuela.
    Ryder E; Ryder S
    J Med Virol; 1983; 11(4):327-32. PubMed ID: 6875522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge.
    Kinney RM; Esposito JJ; Mathews JH; Johnson BJ; Roehrig JT; Barrett AD; Trent DW
    J Virol; 1988 Dec; 62(12):4697-702. PubMed ID: 3184276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular clearance of venezuelan equine encephalomyelitis viruses as a correlate to virulence for rhesus monkeys.
    Jahrling PB; Hilmas DE; Heard CD
    Arch Virol; 1977; 55(1-2):161-4. PubMed ID: 411457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
    Burke DS; Ramsburg HH; Edelman R
    J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.
    Reed DS; Lind CM; Lackemeyer MG; Sullivan LJ; Pratt WD; Parker MD
    Vaccine; 2005 May; 23(24):3139-47. PubMed ID: 15837213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus.
    Grieder FB; Davis BK; Zhou XD; Chen SJ; Finkelman FD; Gause WC
    Virology; 1997 Jul; 233(2):302-12. PubMed ID: 9217054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital cerebral and ocular malformations induced in rhesus monkeys by Venezuelan equine encephalitis virus.
    London WT; Levitt NH; Kent SG; Wong VG; Sever JL
    Teratology; 1977 Dec; 16(3):285-5. PubMed ID: 413204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Walton TE; Alvarez O; Buckwalter RM; Johnson KM
    Infect Immun; 1972 May; 5(5):750-6. PubMed ID: 4637604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venezuelan equine encephalomyelitis virus: concentration, partial purification, inactivation and immunogenicity.
    Foster NM; Barber TL; Walton TE
    Comp Immunol Microbiol Infect Dis; 1983; 6(1):31-7. PubMed ID: 6825417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus.
    Bennett AM; Lescott T; Phillpotts RJ
    Viral Immunol; 1998; 11(3):109-17. PubMed ID: 9918402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Ferguson JA; Reeves WC; Milby MM; Hardy JL
    Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1998 Aug; 16(13):1314-23. PubMed ID: 9682396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.